US Patent 9193745 Heteroleptic iridium complex
Patent 9193745 was granted and assigned to Universal Display Corporation on November, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+273 characters)
Article
Patent abstract
Novel phosphorescent heteroleptic iridium complexes with phenylpyridine and dibenzo-containing ligands are provided. The disclosed compounds have low sublimation temperatures that allow for ease of purification and fabrication into a variety of OLED devices.
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09193745 Heteroleptic iridium complex US Patent 9193745 Heteroleptic iridium complex
Infobox
Patent Number
091937450
Patent Number
91937450
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
091937450
Date of Patent
November 24, 2015
0Patent Application Number
132968060
Date Filed
November 15, 2011
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09193745 Heteroleptic iridium complex
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09193745
Date of patent
November 24, 2015
Patent application number
13296806
Date Filed
November 15, 2011
Patent primary examiner
Find more entities like US Patent 9193745 Heteroleptic iridium complex
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
